Nectar Lifesciences Limited
NECLIFE.BO
Price:
$20.95
Market Cap:
$4.70B
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and mint derivativ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2005-07-19
Stock Exchange
BSE
Ticker
NECLIFE.BO
PE Ratio
[-4.12]
ROE
[-17.69%]
Current Ratio
[0]
Dividend Yield
[0%]
Enterprise Value
[4.70B]
Dividend History
The ROE as of December 2025 (TTM) for Nectar Lifesciences Limited (NECLIFE.BO) is -17.69%
According to Nectar Lifesciences Limited’s latest financial reports and current stock price. The company's current ROE is -17.69%. This represents a change of 272.92% compared to the average of -4.74% of the last 4 quarters.
Nectar Lifesciences Limited (NECLIFE.BO) Historical ROE (quarterly & annually)
How has NECLIFE.BO ROE performed in the past?
The mean historical ROE of Nectar Lifesciences Limited over the last ten years is 0.49%. The current -17.69% ROE has changed -3684.75% with respect to the historical average. Over the past ten years (40 quarters), NECLIFE.BO's ROE was at its highest in in the March 2019 quarter at 1.58%. The ROE was at its lowest in in the March 2025 quarter at -13.61%.
Average
0.49%
Median
2.55%
Minimum
-11.89%
Maximum
5.69%
Nectar Lifesciences Limited (NECLIFE.BO) ROE by Quarter and Year
Discovering the peaks and valleys of Nectar Lifesciences Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 5.69%
Minimum Annual Increase = -2645.21%
Minimum Annual ROE = -11.89%
| Year | ROE | Change |
|---|---|---|
| 2025 | -11.89% | -2645.21% |
| 2024 | 0.47% | -120.57% |
| 2023 | -2.27% | -198.66% |
| 2022 | 2.30% | -133.37% |
| 2021 | -6.90% | -346.55% |
| 2020 | 2.80% | -35.04% |
| 2019 | 4.31% | -12.77% |
| 2018 | 4.94% | -10.18% |
| 2017 | 5.50% | -3.31% |
| 2016 | 5.69% | -17.81% |
Nectar Lifesciences Limited (NECLIFE.BO) Average ROE
How has NECLIFE.BO ROE performed in the past?
The current ROE of Nectar Lifesciences Limited (NECLIFE.BO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-4.56%
5-year avg
-3.66%
10-year avg
0.49%
Nectar Lifesciences Limited (NECLIFE.BO) ROE vs. Peers
How is NECLIFE.BO’s ROE compared to its peers?
Nectar Lifesciences Limited’s ROE is less than ZIM Laboratories Limited (3.79%), less than ZIM Laboratories Limited (3.79%), less than Bafna Pharmaceuticals Limited (9.87%), less than Aarey Drugs & Pharmaceuticals Limited (3.03%), less than Universus Photo Imagings Limited (8.39%), less than Universus Photo Imagings Limited (8.39%), greater than Brooks Laboratories Limited (-0.52%), less than Valiant Laboratories Limited (0.06%), greater than Brooks Laboratories Limited (-0.52%), less than Valiant Laboratories Limited (0.06%),
| Company | ROE | Market cap |
|---|---|---|
| 3.79% | $3.44B | |
| 3.79% | $3.48B | |
| 9.87% | $3.39B | |
| 3.03% | $2.14B | |
| 8.39% | $2.85B | |
| 8.39% | $2.87B | |
| -0.52% | $2.88B | |
| 0.06% | $3.51B | |
| -0.52% | $2.93B | |
| 0.06% | $3.53B |
Build a custom stock screener for Nectar Lifesciences Limited (NECLIFE.BO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nectar Lifesciences Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Nectar Lifesciences Limited (NECLIFE.BO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Nectar Lifesciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Nectar Lifesciences Limited's ROE?
How is the ROE calculated for Nectar Lifesciences Limited (NECLIFE.BO)?
What is the highest ROE for Nectar Lifesciences Limited (NECLIFE.BO)?
What is the 3-year average ROE for Nectar Lifesciences Limited (NECLIFE.BO)?
What is the 5-year average ROE for Nectar Lifesciences Limited (NECLIFE.BO)?
How does the current ROE for Nectar Lifesciences Limited (NECLIFE.BO) compare to its historical average?